DEMECAN

Vertically integrated German medicinal cannabis company DEMECAN announced the successful completion of its latest funding round on Wednesday. According to a person familiar with the matter, the new round brings DEMECAN's valuation close to 100 million euros ($109.24 million), reported Reuters. The...

Editor’s note: The new license allows DEMECAN to increase its annual yield by 2 tons with no specified limit as opposed to increasing its total quantity. Under Germany’s new Medical Cannabis Law (MedCanG), DEMECAN has received a license that allows it to double its production capacity,...

Flora Growth Corp. (NASDAQ:FLGC) has entered into a definitive agreement to acquire all of the issued and outstanding shares of Germany-based TruHC Pharma GmbH. The company’s latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into...

At the Benzinga Cannabis Capital Conference in Hollywood, Florida, Constantin von der Groeben, managing director of Demecan, declared a pivotal moment for global cannabis legislation. ‘We’ve reached a tipping point. I think there’s no stepping back from Germany’s cannabis...

Big League Genetics, a Canadian cannabis nursery and partner of 3WIN Corp, announced on Wednesday that it has completed the export of cannabis genetics to DEMECAN, a licensed German cannabis producer. The move comes shortly after Germany legalized recreational cannabis. As of April 1, adults over...

The second most populated country in Europe, Germany, legalized recently marijuana. What does this mean? Even though Germany's cannabis legalization is partial, it significantly impacts the country’s medical marijuana program, and by enabling personal possession, consumption and...

A week after Germany's cannabis legalization measures were leaked, Health Minister Karl Lauterbach presented a plan to Chancellor Olaf Scholz's cabinet on Wednesday, reported Deutsche Welle. The move comes on the heels of public pushback around certain ...

Prohibition Partners, a European research firm focused on the cannabis industry, has released the first edition of "The Germany Cannabis Report," a 58-page study in which the organization analyzes the landscape of the German cannabis market. With the largest economy in the region and...

Canadian medical cannabis producers Aphria Inc. (NYSE: APHA), Aurora Cannabis Inc. (NYSE: ACB), and Wayland Group Corp (OTC: MRRCF) said they've been selected by the German Federal Institute for Drugs and Medical Devices to cultivate and distribute medical marijuana. What Happened Aurora,...